Clinical Trials
6
Active:0
Completed:5
Trial Phases
4 Phases
Phase 1:1
Phase 2:1
Phase 4:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (50.0%)Not Applicable
1 (16.7%)Phase 1
1 (16.7%)Phase 2
1 (16.7%)The Endurance 1 Trial
Phase 4
Completed
- Conditions
- Diabetic Macular Edema
- Interventions
- Procedure: Focal Laser Treatment
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2019-02-04
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 9
- Registration Number
- NCT02297204
Intravitreal Gas for Vitreomacular Adhesion
Not Applicable
Withdrawn
- Conditions
- Vitreomacular Adhesion
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Registration Number
- NCT02001701
- Locations
- 🇺🇸
Northern California Retina Vitreous Associates, Mountain View, California, United States
Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.
Phase 1
Completed
- Conditions
- Recalcitrant Wet Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2013-10-30
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 12
- Registration Number
- NCT01972763
- Locations
- 🇺🇸
Northern California Retina Vitreous Associates, Mountain View, California, United States
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
Phase 4
Completed
- Conditions
- Macular Edema With Central Retinal Vein Occlusions
- Interventions
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 20
- Registration Number
- NCT01870427
- Locations
- 🇺🇸
Northern California Retina Vitreous Associates, Mountain View, California, United States
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
Phase 4
Completed
- Conditions
- UveitisMacular Edema
- Interventions
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Northern California Retina Vitreous Associates
- Target Recruit Count
- 10
- Registration Number
- NCT01870440
- Locations
- 🇺🇸
Northern California Retina Vitreous Associates, Mountain View, California, United States
- Prev
- 1
- 2
- Next
News
No news found